UnitedHealth’s Campaign to Quiet Critics
“Negative publicity may adversely affect our stock price, damage our reputation and expose us to unexpected or unwarranted regulatory scrutiny,” UnitedHealth noted in its most recent annual report. The company’s shares have declined 40 percent over the past year.
2 replies
“Negative publicity may adversely affect our stock price, damage our reputation and expose us to unexpected or unwarranted regulatory scrutiny,”
I can't imagine how awful that must be! I mean, it sucks to be denied life-saving care because United Health puts profit over patients--but unwanted regulatory scrutiny? What kind of monster would do that?!